معرفی
Abhipree Sharma is a Research Fellow in the Drug Discovery Biology department at Monash University, where she conducts advanced research on cardiometabolic diseases, particularly focusing on the cardiac complications of type 2 diabetes and sex-specific responses to glucose-lowering therapies. Her work bridges pharmacology, endocrinology, and cardiovascular medicine.
Her research interests include cardiac fibrosis, adiponectin signaling, sex differences in cardiovascular disease, and the therapeutic potential of SGLT2 inhibitors and GLP-1 receptor agonists. These areas are central to understanding how diabetes impacts heart health differently in men and women.
The trends in her recent publications indicate a strong focus on translational pharmacology, with an emphasis on population-based evidence and molecular mechanisms underlying diabetic cardiomyopathy. Her work frequently explores how metabolic therapies confer cardioprotection, particularly through anti-fibrotic and anti-inflammatory pathways.
Abhipree Sharma has published in high-impact journals such as The Lancet Regional Health - Western Pacific and British Journal of Pharmacology, contributing to both clinical and mechanistic understanding of diabetes-related heart disease.
She is actively involved in collaborative research with prominent scientists including Dr. Rebecca H. Ritchie and Dr. Melissa J. De Blasio. While no formal advisees or grant details are listed, her consistent output suggests active participation in funded research programs. She contributes to global health goals related to non-communicable diseases and personalized medicine.
